DIFFERENCES IN THE EXPRESSION OF ALKALINE-PHOSPHATASE MESSENGER-RNA IN CHRONIC MYELOGENOUS LEUKEMIA AND PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA POLYMORPHONUCLEAR LEUKOCYTES
- 1 April 1989
- journal article
- research article
- Vol. 73 (5) , 1113-1115
Abstract
Paroxysomal nocturnal hemoglobinuria (PNH) and the stable phase of chronic myelogenous leukemia (CML) are the two hematological conditions known to be associated with low levels of leukocyte alkaline phosphatase (LAP) activity in peripheral blood polymorphonulcear cells (PMN). LAP mRNA levels were determined in PMN from PNH and CML patients by RNA blotting analysis. In CML, LAP mRNA is undetectable, suggesting either decreased transcription or rapid degradation of the message. Contrarily, in PNH normal or high levels of LAP mRNA are present. This latter finding supports the concept of a deficit in the anchorage of the protein to the plasma membrane through the glycolipid pathway, even though other post-transcriptional mechanisms clould be involved.This publication has 14 references indexed in Scilit:
- Release of decay-accelerating factor (DAF) from the cell membrane by phosphatidylinositol-specific phospholipase C (PIPLC). Selective modification of a complement regulatory protein.The Journal of Experimental Medicine, 1986
- INVITRO MODULATION OF ALKALINE-PHOSPHATASE ACTIVITY IN NEUTROPHILS FROM PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA BY MONOCYTE-DERIVED ACTIVITY1986
- Purification and partial sequencing of bovine liver alkaline phosphataseArchives of Biochemistry and Biophysics, 1985
- THE ACETYLCHOLINESTERASE DEFECT IN PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA - EVIDENCE THAT THE ENZYME IS ABSENT FROM THE CELL-MEMBRANE1985
- Studies of the biochemical and immunological properties of human neutrophil alkaline phosphatase with comparison to the established alkaline phosphatase isoenzymesClinica Chimica Acta; International Journal of Clinical Chemistry, 1984
- Affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria are deficient in the complement regulatory protein, decay accelerating factor.Proceedings of the National Academy of Sciences, 1983
- A technique for radiolabeling DNA restriction endonuclease fragments to high specific activityAnalytical Biochemistry, 1983
- FACTOR(S) RESPONSIBLE FOR THE INCREASE IN ALKALINE-PHOSPHATASE ACTIVITY OF POST-MITOTIC GRANULOCYTES FROM NORMAL INDIVIDUALS AND PATIENTS WITH CHRONIC MYELOID-LEUKEMIA1982
- Neutrophil (Leucocyte) Alkaline Phosphatase in Paroxysmal Nocturnal HaemoglobinuriaBritish Journal of Haematology, 1965
- Chronic Granulocytic Leukemia Complicated by Ulcerative Colitis: Elevated Leukocyte Alkaline Phosphatase and Possible Modifier Gene DeletionBlood, 1965